Avosentan is a competitive antagonist of Endothelin-1 (ET-1) with a high selectivity for the ETA receptor. Avosentan may be a potential option in the treatment of glaucoma.
Molecular Weight:
479.51
CAS Number:
[290815-26-8]
* VAT and and shipping costs not included. Errors and price changes excepted